Comparing a cosmetic product for treating facial acne in young adults
A Randomized Investigator-blinded Comparative Study to Assess the Efficacy of the Cosmetic Care Product RV4133C - Formula JT2559 in Subjects With Facial Acne, During a 3-month-associated-treatment Phase Followed by a 3-month-maintenance Phase
This study tests whether a new cosmetic product can help teenagers and young adults with acne when used alongside their regular acne treatment.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 60 (estimated) |
| Ages | 14 Years to 24 Years |
| Sex | All |
| Sponsor | Pierre Fabre Dermo Cosmetique Industry-sponsored |
| Locations | 1 site (São Paulo) |
| Trial ID | NCT06716398 on ClinicalTrials.gov |
What this trial studies
This study evaluates the effectiveness of a cosmetic product as complementary care alongside a prescribed topical medical treatment for facial acne in teenagers and young adults. Participants will undergo a 3-month associated treatment phase followed by a 3-month maintenance phase, during which the cosmetic product will be compared to a light moisturizing cream. The study aims to assess both the global benefits and the tolerance of the tested product in conjunction with the medical treatment.
Who should consider this trial
Good fit: Ideal candidates are males and females aged 14 to 24 with mild to moderate facial acne.
Not a fit: Patients with severe forms of acne or other facial skin diseases may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could provide an effective cosmetic solution to enhance acne treatment outcomes for young patients.
How similar studies have performed: Other studies have shown promising results with similar approaches in improving acne treatment outcomes.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Male or Female aged between 14 and 24 years (included) * Subject with facial acne with score index severity IGA = 2 or 3, assessed on a scale ranged from 0 to 4. * Subject for whom a prescription of 12 weeks of a reference topical medical treatment is required from the day of the inclusion visit, for mild to moderate face acne Exclusion Criteria: Criteria related to the disease: * Facial skin disease other than acne, skin abnormalities, or dermatological condition on the face liable to interfere with the study assessments * Acne conglobata, Acne fulminans, nodulocystic acne or acneiform eruptions, according to investigator's assessment * Other type of pigmentation disorder than acne-related PIH liable to interfere with the study assessments according to the investigator Criteria related to treatments and/or products: \- Topical or oral treatment established or modified during the previous weeks or planned to be established or modified during the study, liable to interfere with the evaluation of the efficacy or cutaneous tolerance of the investigational products
Where this trial is running
São Paulo
- Unifesp — São Paulo, Brazil (Recruiting)
Study contacts
- Study coordinator: Adeline Bacquey
- Email: adeline.bacquey@pierre-fabre.com
- Phone: +33562877753
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.